HIKAL LTD.

Hikal Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is effective from July 01, 2026, and will remain in effect until 48 hours after the declaration of the financial results for the quarter ending June 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, aimed at preventing potential insider trading during sensitive financial reporting periods.

Hikal Ltd announced its audited financial results for the quarter and year ended March 31, 2026. The company reported revenue of ₹519 crore for Q4FY26 and ₹1,713 crore for the full year FY26. EBITDA stood at ₹105 crore for the quarter, with margins of 20.3%. The Board has approved a final dividend of 20% of FV, bringing the total dividend for the year to 30%. The company's long-term credit rating is A (Stable) by ICRA. The Pharmaceutical business showed sequential improvement, while the Crop Protection business accelerated during the quarter. Hikal is focusing on diversification into Personal Care and Specialty Chemicals.

The Board of Directors of Hikal Ltd approved the audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹0.40 per equity share (20%) subject to shareholder approval at the upcoming AGM. This brings the total dividend for FY26 to ₹0.60 per share, including an interim dividend of ₹0.20 paid in March 2026. The board also approved the appointment of Mr. Sandip Parikh as an Additional Independent Director for five years, effective May 27, 2026. The trading window will re-open on May 30, 2026.

Hikal Ltd announced the appointment of Mr. Ravi Khadabadi as President-Crop Protection & Specialty Chemicals, effective May 27, 2026. The company also addressed previous disclosure regarding revenue recognition irregularities as of September 30, 2025. An external review found irregularities limited to preponement of genuine sales. Corrective actions were implemented, and the involved employees were relieved from their services. The company concludes that there is no impact of this matter on the current or previous periods.

Hikal Ltd's board meeting on May 27, 2026, approved audited financial results for FY26, recommended a final dividend of ₹0.40 per share (total ₹0.60 including interim), and appointed Sandip Parikh as an Additional Independent Director for 5 years, subject to shareholder approval. The trading window re-opens on May 30, 2026.

Hikal Ltd announced the appointment of Mr. Ravi Khadabadi as President-Crop Protection & Specialty Chemicals, effective May 27, 2026. The company also addressed previously disclosed irregularities related to revenue recognition, stating that a fact-finding review revealed the issue was limited to the preponement of underlying genuine sales. Corrective actions have been implemented, and management concludes there is no impact on current or previous periods. Employees involved have been relieved from their services.

Hikal Ltd announced the appointment of Mr. Ravi Khadabadi as President-Crop Protection & Specialty Chemicals, effective May 27, 2026. The company also addressed previously disclosed irregularities related to revenue recognition, stating that a fact-finding review revealed preponement of genuine sales. Corrective actions have been implemented, and management concludes there is no impact on current or previous periods. Employees involved have been relieved from their services.

Hikal Ltd's board approved audited financial results for FY26 and recommended a final dividend of ₹0.40 per equity share (20%) subject to shareholder approval. This brings the total dividend for FY26 to ₹0.60 per share, including an interim dividend of ₹0.20. The board also approved the appointment of Mr. Sandip Parikh as an Additional Independent Director for 5 years, effective May 27, 2026. The trading window will re-open on May 30, 2026.

Hikal Ltd's Board of Directors approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. They recommended a final dividend of ₹0.40 per equity share (20%) for FY26, subject to shareholder approval. The board also approved the appointment of Mr. Sandip Parikh as an Additional Independent Director for a 5-year term starting May 27, 2026. The trading window will re-open on May 30, 2026.

Hikal Ltd has announced that a meeting of the Board of Directors is scheduled for May 27, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board will also consider recommending the payment of a final dividend for the financial year 2025-26, subject to shareholder approval at the 38th Annual General Meeting.